IVIM Health vs TrimRx (2026): prices, structure, verdict
On tirzepatide, IVIM Health↗ is cheaper: $278 versus $349 a month all-in — a $71 monthly gap, $852 across a year of maintenance dosing.
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
On semaglutide, IVIM Health is cheaper: $149 versus $299 a month all-in — a $150 monthly gap, $1,800 across a year of maintenance dosing.
IVIM Health
- Tirzepatide all-in
- $278/mo
- Semaglutide all-in
- $149/mo
- 12-mo tirzepatide (best path)
- $3,336
- Membership
- $75/mo (inside figures)
- Shipping
- included
- Commitment
- membership mandatory for duration
- Cancellation
- membership mandatory
- Pharmacy
- not named
- States
- not published
- Insurance
- no
- Evidence
- source-verified · 2026-08-05
TrimRx
- Tirzepatide all-in
- $349/mo · flat
- Semaglutide all-in
- $299/mo · flat
- 12-mo tirzepatide (best path)
- $4,188
- Membership
- none
- Shipping
- included
- Commitment
- none month-to-month
- Cancellation
- check terms before prepaying
- Pharmacy
- not named
- States
- not published
- Insurance
- no
- Evidence
- source-verified · 2026-08-05
The two records, condensed
IVIM Health: the record, condensed
Start with the load-bearing figure: $278 a month, all-in, is what IVIM Health charges for tirzepatide at the 10 mg basis. Note the shape: $208 is the number in the marketing, $278 is the number at maintenance. The $70 difference is not a fee or a trick per se — it is dose-tiered pricing doing what dose-tiered pricing does — but it means the advertised figure describes month one, not month twelve.
A required $75/month membership is part of the deal, and part of the figure above: $203 of medication plus $75 of platform equals the $278 that leaves your account. Judge the membership by what it includes, but compare on the total.
To place the number: #3 of 17 verified programs, with the floor $63/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $171 a month. A year at this figure: $3,336 monthly-billed.
On semaglutide, the number that matters at IVIM Health is $149 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. The figure is quoted at maintenance without a separate teaser tier, which keeps the arithmetic honest by default.
A required $75/month membership is part of the deal, and part of the figure above: $74 of medication plus $75 of platform equals the $149 that leaves your account. Judge the membership by what it includes, but compare on the total.
Context for that figure: it ranks #3 of 20 in the verified semaglutide index — $16/month above the floor (Oak Longevity, $133) — and sits $200 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $1,788.
Operationally at IVIM Health: shipping included; commitment membership mandatory for duration; cancellation membership mandatory; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the IVIM Health page · visit IVIM Health ↗
TrimRx: the record, condensed
TrimRx’s tirzepatide program bills $349 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at TrimRx is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.
Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $349 is the whole subscription, which makes TrimRx unusually easy to compare and unusually easy to leave.
To place the number: #11 of 17 verified programs, with the floor $134/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $100 a month. A year at this figure: $4,188 monthly-billed.
On semaglutide, the number that matters at TrimRx is $299 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at TrimRx is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.
There is no membership line. $299 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.
Context for that figure: it ranks #17 of 20 in the verified semaglutide index — $166/month above the floor (Oak Longevity, $133) — and sits $50 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $3,588.
Operationally at TrimRx: shipping included; commitment none month-to-month; cancellation check terms before prepaying; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the TrimRx page · visit TrimRx ↗
Tirzepatide: the duel in full
Put the two tirzepatide figures side by side and hold them there: IVIM Health at $278, TrimRx at $349 — a $71 monthly spread that compounds to $852 over a maintenance year and $1,704 over two.
Structure sharpens the gap: TrimRx’s figure is dose-flat (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill the same), while IVIM Health’s is not — so TrimRx’s number is a ceiling and IVIM Health’s advertised entry ($208) is a floor. Comparing a ceiling to a floor flatters the floor; this site compares maintenance to maintenance, which is the table above.
IVIM Health’s total includes a mandatory $75/month membership; TrimRx has none. The all-in figures above neutralize that difference — but the membership side has an exit consideration the other lacks: a fee that recurs until you affirmatively cancel it.
Semaglutide: the duel in full
The semaglutide arithmetic between these two is short: $149 (IVIM Health) against $299 (TrimRx). $150 a month sounds survivable; $1,800 a year is a decision.
Structure sharpens the gap: TrimRx’s figure is dose-flat (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill the same), while IVIM Health’s is not — so TrimRx’s number is a ceiling and IVIM Health’s advertised entry ($149) is a floor. Comparing a ceiling to a floor flatters the floor; this site compares maintenance to maintenance, which is the table above.
IVIM Health’s total includes a mandatory $75/month membership; TrimRx has none. The all-in figures above neutralize that difference — but the membership side has an exit consideration the other lacks: a fee that recurs until you affirmatively cancel it.
A way to feel the $71 monthly gap: over a year it funds 3.1 extra months at IVIM Health’s own rate — the difference is not decoration, it is medication. Over two years it compounds to $1,704, which is the horizon at which structural details (prepaid ladders, membership drag, dose-tier repricing) start mattering more than the sticker itself.
Run the same two programs on the committed basis: IVIM Health $278/mo month-to-month against TrimRx $349/mo month-to-month. The order holds: IVIM Health leads on both readings, so plan structure sharpens the verdict here rather than reversing it. Whichever basis fits your commitment level, the upfront totals above are the honest units.
Three, six, twelve, twenty-four months — best path each way
3 months: IVIM Health $834 monthly; TrimRx $1,047 monthly — best path favors IVIM Health by $213. 6 months: IVIM Health $1,668 monthly; TrimRx $2,094 monthly — best path favors IVIM Health by $426. 12 months: IVIM Health $3,336 monthly; TrimRx $4,188 monthly — best path favors IVIM Health by $852. 24 months: IVIM Health $6,672 monthly; TrimRx $8,376 monthly — best path favors IVIM Health by $1,704.
Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.
The same clock, on semaglutide
3 mo: IVIM Health $447 vs TrimRx $897 — $450 to IVIM Health. 6 mo: IVIM Health $894 vs TrimRx $1,794 — $900 to IVIM Health. 12 mo: IVIM Health $1,788 vs TrimRx $3,588 — $1,800 to IVIM Health. 24 mo: IVIM Health $3,576 vs TrimRx $7,176 — $3,600 to IVIM Health.
Same rules as above: prepaid figures are upfront commitments, and the 24-month lines extend the 12-month rate as a stated assumption. Where the two molecules crown different winners between these two programs, that split is itself the finding — molecule choice and provider choice are separate decisions.
Everything besides the price
Coverage: IVIM Health publishes “not published”; TrimRx publishes “not published” — for anything short of an explicit 50-state claim, intake is the final word.
Neither names its pharmacy publicly — the single most useful disclosure in this category, missing on both sides; ask each, in writing, before paying either.
Exit terms: IVIM Health — membership mandatory for duration; membership mandatory. TrimRx — none month-to-month; check terms before prepaying.
Evidence: IVIM Health source-verified (captured 2026-08-05); TrimRx source-verified (2026-08-05).
The pattern worth internalizing: in this market, structural honesty and price honesty travel together. Programs that publish pharmacies and state lists tend to publish real maintenance prices; programs that hide one usually hide the other.
In the full tirzepatide index these two sit at #3 and #11 of 17: between them lie 7 other programs, and the whole ladder is at cheapest tirzepatide providers. In the full semaglutide index these two sit at #3 and #17 of 20: between them lie 13 other programs, and the whole ladder is at cheapest semaglutide providers.
Switching between IVIM Health and TrimRx
Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (IVIM Health: membership mandatory; TrimRx: check terms before prepaying) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.
Which one, for whom
Cheapest tirzepatide month-to-month: IVIM Health ($278).
Cheapest 12-month path: IVIM Health at $3,336 (monthly billing).
Cheapest semaglutide: IVIM Health ($149).
Simplest billing: TrimRx — no membership; IVIM Health's $75/mo membership recurs until cancelled.
Add a third program
The compressed verdict: choose IVIM Health when the $71/month ($852/year) gap is doing the deciding and its structure fits; choose TrimRx when a specific thing it offers — its particular program design — is worth more to you than $852 a year; and choose neither before running your own dose path and horizon through the calculator, because the ranking that matters is the one at your numbers.
Verdicts are computed from the records above — recompute them from the dataset. Full profiles: IVIM Health · TrimRx.
Frequently asked
Which is cheaper, IVIM Health or TrimRx?
On tirzepatide, IVIM Health is cheaper: $278 versus $349 a month all-in — a $71 monthly gap, $852 across a year of maintenance dosing. On semaglutide, IVIM Health is cheaper: $149 versus $299 a month all-in — a $150 monthly gap, $1,800 across a year of maintenance dosing.
Is there a membership fee at IVIM Health or TrimRx?
IVIM Health: $75/month, mandatory and already included in the figures here. TrimRx: none.
Where do these numbers come from?
From each provider's own published pages, captured 2026-08-05 (IVIM Health) and 2026-08-05 (TrimRx), normalized to the all-in maintenance basis and archived. Full records: the provider pages and the public dataset.
What does a year of tirzepatide cost at IVIM Health vs TrimRx?
IVIM Health: $3,336 monthly-billed. TrimRx: $4,188. Best-path difference: $852 in favor of IVIM Health.
What does a year of semaglutide cost at IVIM Health vs TrimRx?
IVIM Health: $1,788 monthly-billed. TrimRx: $3,588. Best-path difference: $1,800 in favor of IVIM Health.
Is IVIM Health or TrimRx dose-flat?
IVIM Health: no flat structure verified — get the maintenance-dose price in writing. TrimRx: yes — flat across doses. Flat pricing turns the advertised number into a ceiling; tiered pricing makes it a floor.
Can I check both IVIM Health and TrimRx against their sources?
Yes — that is the design. Each record carries a capture date (2026-08-05 / 2026-08-05), a source link, and an archive link in the database; the figures on this page regenerate from those records, so any discrepancy you find is reportable and fixable sitewide in one pass.
What states do IVIM Health and TrimRx serve?
IVIM Health: not published. TrimRx: not published. Telehealth availability rides on clinician licensure and pharmacy permits, so for anything short of an explicit 50-state claim the enrollment flow is the final word; the state-by-state index adds the known exceptions.
Is shipping included at IVIM Health and TrimRx?
IVIM Health: included. TrimRx: included. Cold-chain delivery is a real cost; programs that fold it into the all-in figure remove a checkout surprise, and any separate shipping line belongs in your comparison math before the prices above are treated as equivalent.
Which is more transparent, IVIM Health or TrimRx?
On the checkable axes: pharmacy named — IVIM Health no, TrimRx no; state list — IVIM Health published, TrimRx published; cancellation terms — IVIM Health published, TrimRx published; evidence — source-verified vs source-verified. Disclosure predicts disclosure in this market, and the axis where one of these two goes quiet is usually where your intake questions should get loud.